LENZ Therapeutics (LENZ) Inventory (2020 - 2026)

LENZ Therapeutics (LENZ) posted quarterly Inventory of $3.5 million for Q1 2026, up 19.14% quarter-over-quarter from $2.9 million in Q4 2025.

LENZ Therapeutics (LENZ) Inventory (2020 - 2026) Analysis & Trends

LENZ Therapeutics (LENZ) has reported Inventory for 6 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

In Q1 2026, Inventory changed N/A year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (changed N/A YoY), while the FY2025 annual figure was $2.9 million, changed N/A from the prior year.
Inventory grew to $3.5 million in Q1 2026 per LENZ's latest filing, from $2.9 million in the prior quarter.
Across five years, Inventory topped out at $3.5 million in Q1 2026 and bottomed at $39000.0 in Q2 2023.
Historically, Inventory has averaged $2.0 million across 4 years, with a median of $2.1 million in 2023.
Annual changes were most pronounced in 2022 — Inventory jumped 35.55% — and 2023, when it tumbled 97.68%.
LENZ Therapeutics' Inventory stood at $2.5 million in 2022, then sank by 98.43% to $39000.0 in 2023, then jumped by 7428.21% to $2.9 million in 2025, then gained by 19.14% to $3.5 million in 2026.
Business Quant data shows LENZ's Inventory at $3.5 million in Q1 2026, $2.9 million in Q4 2025, and $949000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Vertex Pharmaceuticals	138.90 Bn	131.05 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	86.10 Bn	78.11 Bn	3.93 Bn	3.08 Bn
3	Argenx Se	65.56 Bn	60.37 Bn	1.37 Bn	371.00 Mn
4	Moderna	55.82 Bn	50.68 Bn	52.00 Mn	280.00 Mn
5	BeOne Medicines	42.14 Bn	37.04 Bn	1.53 Bn	732.60 Mn
6	Alnylam Pharmaceuticals	31.67 Bn	28.36 Bn	992.69 Mn	97.11 Mn
7	BioNTech SE	27.74 Bn	9.35 Bn	668.28 Mn	128.86 Mn
8	Insmed	27.53 Bn	26.37 Bn	358.27 Mn	142.38 Mn
9	Royalty Pharma	27.38 Bn	26.54 Bn	-	-
10	LENZ Therapeutics	147.46 Mn	147.46 Mn	5.21 Mn	4.12 Mn

Download Data